Development of a primary cell HIV latency model (version 1)

• Research type

  Research Study

• Full title

  Development of a primary cell HIV latency model using peripheral blood mononuclear cells from HIV+ve individuals on suppressive antiretroviral medication for the assessment of new therapeutic agents, antigenicity and vaccine design.

• IRAS ID

  108083

• Contact name

  Alexander John Frater

• Contact email

  john.frater@ndm.ox.ac.uk

• Sponsor organisation

  Oxford Radcliffe Hospitals NHS Trust

• REC name

  South Central - Oxford B Research Ethics Committee

• REC reference

  12/SC/0679

• Date of REC Opinion

  7 Feb 2013

• REC opinion

  Further Information Favourable Opinion